[Present-day management of the general treatment of diabetic retinopathy].
D045930:Anabolic Agents / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002123:Calcium Dobesilate / Q000627:therapeutic use*; D002994:Clofibrate / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery; D004176:Dipyridamole / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007016:Hypophysectomy; D053685:Laser Therapy; D010208:Papaverine / Q000627:therapeutic use
D045930:Anabolic Agents; D000924:Anticholesteremic Agents; D001557:Benzenesulfonates; D002123:Calcium Dobesilate; D004176:Dipyridamole; D006493:Heparin; D010208:Papaverine; D002994:Clofibrate
Conduita actuală privind tratamentul general al retinopatiei diabetice.